Tapewire

NYSE · USD

UNH

UNITEDHEALTH GROUP INC

Export transactions ↓
Tapewire entity
2809
SEC CIK
0000731766
Parsed reports
3,134

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 13, 2012 Filed Feb 14, 2012 21:46 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $22.12 $0.00
Disclosure

SEC source: 0001209191-12-009970 · doc4.xml · derivative · entry 14

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2012-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2012 Filed Feb 14, 2012 21:46 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,240 $0.00 Strike: $21.08 $0.00
Disclosure

SEC source: 0001209191-12-009970 · doc4.xml · derivative · entry 13

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,240 shares

Expires 2012-08-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2012 Filed Feb 14, 2012 21:46 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $23.09 $0.00
Disclosure

SEC source: 0001209191-12-009970 · doc4.xml · derivative · entry 12

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2012-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2012 Filed Feb 14, 2012 21:46 UTC GrantCommon Stock 1,920 $23.67 $45,446.40
Disclosure

SEC source: 0001209191-12-009970 · doc4.xml · nonDerivative · entry 4

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 924,836

Read SEC document
February 13, 2012 Filed Feb 14, 2012 21:46 UTC GrantCommon Stock 10,000 $22.12 $221,175.00
Disclosure

SEC source: 0001209191-12-009970 · doc4.xml · nonDerivative · entry 3

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 922,916

Read SEC document
February 13, 2012 Filed Feb 14, 2012 21:46 UTC GrantCommon Stock 2,240 $21.08 $47,208.00
Disclosure

SEC source: 0001209191-12-009970 · doc4.xml · nonDerivative · entry 2

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 912,916

Read SEC document
February 13, 2012 Filed Feb 14, 2012 21:46 UTC GrantCommon Stock 10,000 $23.09 $230,875.00
Disclosure

SEC source: 0001209191-12-009970 · doc4.xml · nonDerivative · entry 1

LEATHERDALE DOUGLAS W · CIK 0001024367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 910,676

Read SEC document
February 13, 2012 Filed Feb 14, 2012 21:46 UTC
WELTERS ANTHONYEVP, UnitedHealth Group
SaleCommon Stock 76,000 $53.58 $4,071,753.20
Disclosure

SEC source: 0001209191-12-009974 · doc4.xml · nonDerivative · entry 1

WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,641.012

F1 · price: This transaction was executed in multiple trades ranging from $53.41 to $53.65 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:30 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $23.09 $0.00
Disclosure

SEC source: 0001209191-12-009039 · doc4.xml · derivative · entry 5

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2012-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:30 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $18.97 $0.00
Disclosure

SEC source: 0001209191-12-009039 · doc4.xml · derivative · entry 4

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2012-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:30 UTC SaleCommon Stock 20,000 $53.04 $1,060,804.00
Disclosure

SEC source: 0001209191-12-009039 · doc4.xml · nonDerivative · entry 3

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,761

F1 · price: This transaction was executed in multiple trades ranging from $53.03 to $53.05 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:30 UTC Exercise / conversionCommon Stock 10,000 $23.09 $230,880.00
Disclosure

SEC source: 0001209191-12-009039 · doc4.xml · nonDerivative · entry 2

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:30 UTC Exercise / conversionCommon Stock 10,000 $18.97 $189,720.00
Disclosure

SEC source: 0001209191-12-009039 · doc4.xml · nonDerivative · entry 1

BALLARD WILLIAM C JR · CIK 0001024398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,761

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:31 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
Tax withholdingCommon Stock 3,235 $53.06 $171,649.10
Disclosure

SEC source: 0001209191-12-009044 · doc4.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,453.327

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:31 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
Tax withholdingCommon Stock 7,709 $53.06 $409,039.54
Disclosure

SEC source: 0001209191-12-009044 · doc4.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,688.327

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:31 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Tax withholdingCommon Stock 4,688 $53.06 $248,745.28
Disclosure

SEC source: 0001209191-12-009047 · doc4.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,793,539.872

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:31 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Tax withholdingCommon Stock 10,237 $53.06 $543,175.22
Disclosure

SEC source: 0001209191-12-009047 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,798,227.872

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:32 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
Tax withholdingCommon Stock 3,126 $53.06 $165,865.56
Disclosure

SEC source: 0001209191-12-009051 · doc4.xml · nonDerivative · entry 2

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 295,248.546

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:32 UTC
MUNSELL WILLIAM AEVP, UnitedHealth Group
Tax withholdingCommon Stock 5,941 $53.06 $315,229.46
Disclosure

SEC source: 0001209191-12-009051 · doc4.xml · nonDerivative · entry 1

MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,374.546

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:32 UTC
RANGEN ERIC SSr VP & Chief Acctg Officer
Tax withholdingCommon Stock 620 $53.06 $32,897.20
Disclosure

SEC source: 0001209191-12-009053 · doc4.xml · nonDerivative · entry 2

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,692.532

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:32 UTC
RANGEN ERIC SSr VP & Chief Acctg Officer
Tax withholdingCommon Stock 1,312 $53.06 $69,614.72
Disclosure

SEC source: 0001209191-12-009053 · doc4.xml · nonDerivative · entry 1

RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,312.532

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:33 UTC
RENFRO LARRY CEVP, UnitedHealth Group
Tax withholdingCommon Stock 3,235 $53.06 $171,649.10
Disclosure

SEC source: 0001209191-12-009058 · doc4.xml · nonDerivative · entry 2

RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,144.085

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:33 UTC
RENFRO LARRY CEVP, UnitedHealth Group
Tax withholdingCommon Stock 7,709 $53.06 $409,039.54
Disclosure

SEC source: 0001209191-12-009058 · doc4.xml · nonDerivative · entry 1

RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,379.085

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Sweere LoriEVP, Human Capital
Tax withholdingCommon Stock 1,239 $53.06 $65,741.34
Disclosure

SEC source: 0001209191-12-009060 · doc4.xml · nonDerivative · entry 2

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,308.552

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Sweere LoriEVP, Human Capital
Tax withholdingCommon Stock 2,624 $53.06 $139,229.44
Disclosure

SEC source: 0001209191-12-009060 · doc4.xml · nonDerivative · entry 1

Sweere Lori · CIK 0001407932 · EVP, Human Capital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,547.552

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 110,000 $0.00 Strike: $42.87 $0.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · derivative · entry 12

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 110,000 shares

Expires 2014-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock options vested at a rate of 50% annually on November 4 from the years 2007 through 2008.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 110,000 $0.00 Strike: $43.68 $0.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · derivative · entry 11

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 110,000 shares

Expires 2014-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options vested at a rate of 50% annually on November 4 from the years 2005 through 2006.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 17,500 $0.00 Strike: $28.10 $0.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · derivative · entry 10

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires 2013-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 52,500 $0.00 Strike: $30.98 $0.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · derivative · entry 9

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,500 shares

Expires 2013-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options vested at a rate of 33% annually on October 28 from the years 2004 through 2006.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
SaleCommon Stock 290,000 $53.12 $15,405,206.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · nonDerivative · entry 7

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,026.866

F1 · price: This transaction was executed in multiple trades ranging from $53.09 to $53.145 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionCommon Stock 110,000 $42.87 $4,715,150.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · nonDerivative · entry 6

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 410,026.866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionCommon Stock 110,000 $43.68 $4,804,690.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · nonDerivative · entry 5

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,026.866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionCommon Stock 17,500 $28.10 $491,750.00
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · nonDerivative · entry 4

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,026.866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Exercise / conversionCommon Stock 52,500 $30.98 $1,626,397.50
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · nonDerivative · entry 3

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,526.866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Tax withholdingCommon Stock 2,914 $53.06 $154,616.84
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · nonDerivative · entry 2

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,026.866

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:34 UTC
Tuckson Reed VaughnEVP & Chief of Medical Affairs
Tax withholdingCommon Stock 2,322 $53.06 $123,205.32
Disclosure

SEC source: 0001209191-12-009064 · doc4.xml · nonDerivative · entry 1

Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,940.866

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:35 UTC
WELTERS ANTHONYEVP, UnitedHealth Group
Tax withholdingCommon Stock 3,088 $53.06 $163,849.28
Disclosure

SEC source: 0001209191-12-009066 · doc4.xml · nonDerivative · entry 2

WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,641.012

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:35 UTC
WELTERS ANTHONYEVP, UnitedHealth Group
Tax withholdingCommon Stock 5,862 $53.06 $311,037.72
Disclosure

SEC source: 0001209191-12-009066 · doc4.xml · nonDerivative · entry 1

WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,729.012

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:35 UTC
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 200,000 $0.00 Strike: $22.11 $0.00
Disclosure

SEC source: 0001209191-12-009069 · doc4.xml · derivative · entry 6

WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200,000 shares

Expires 2012-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options vested at a rate of 25% annually on August 5 from the years 2003 through 2006.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:35 UTC
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
SaleCommon Stock 200,000 $53.21 $10,641,280.00
Disclosure

SEC source: 0001209191-12-009069 · doc4.xml · nonDerivative · entry 4

WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,106.267

F1 · price: This transaction was executed in multiple trades ranging from $53.045 to $53.40 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:35 UTC
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
Exercise / conversionCommon Stock 200,000 $22.11 $4,422,000.00
Disclosure

SEC source: 0001209191-12-009069 · doc4.xml · nonDerivative · entry 3

WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 538,106.267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:35 UTC
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
Tax withholdingCommon Stock 3,235 $53.06 $171,649.10
Disclosure

SEC source: 0001209191-12-009069 · doc4.xml · nonDerivative · entry 2

WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,106.267

Read SEC document
February 09, 2012 Filed Feb 10, 2012 21:35 UTC
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
Tax withholdingCommon Stock 6,754 $53.06 $358,367.24
Disclosure

SEC source: 0001209191-12-009069 · doc4.xml · nonDerivative · entry 1

WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,341.267

Read SEC document
February 07, 2012 Filed Feb 9, 2012 21:37 UTC
BAER RICHARD NEVP & Chief Legal Officer
GrantCommon Stock 28,830 $52.03 $1,500,024.90
Disclosure

SEC source: 0001209191-12-008705 · doc4.xml · nonDerivative · entry 1

BAER RICHARD N · CIK 0001241852 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,713.135

F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015.

F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 28,830.

Read SEC document
February 07, 2012 Filed Feb 9, 2012 21:38 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
Tax withholdingCommon Stock 65,693 $52.03 $3,418,006.79
Disclosure

SEC source: 0001209191-12-008707 · doc4.xml · nonDerivative · entry 3

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,397.327

F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011.

F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 43,245.

Read SEC document
February 07, 2012 Filed Feb 9, 2012 21:38 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
GrantCommon Stock 153,846 $0.00 $0.00
Disclosure

SEC source: 0001209191-12-008707 · doc4.xml · nonDerivative · entry 2

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 383,090.327

F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011.

Read SEC document
February 07, 2012 Filed Feb 9, 2012 21:38 UTC
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
GrantCommon Stock 43,245 $52.03 $2,250,037.35
Disclosure

SEC source: 0001209191-12-008707 · doc4.xml · nonDerivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,244.327

F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015.

Read SEC document
February 07, 2012 Filed Feb 9, 2012 21:39 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
Tax withholdingCommon Stock 98,539 $52.03 $5,126,984.17
Disclosure

SEC source: 0001209191-12-008709 · doc4.xml · nonDerivative · entry 3

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,808,464.872

F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011.

F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 67,269.

Read SEC document
February 07, 2012 Filed Feb 9, 2012 21:39 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
GrantCommon Stock 230,770 $0.00 $0.00
Disclosure

SEC source: 0001209191-12-008709 · doc4.xml · nonDerivative · entry 2

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907,003.872

F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011.

Read SEC document
February 07, 2012 Filed Feb 9, 2012 21:39 UTC
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
GrantCommon Stock 67,269 $52.03 $3,500,006.07
Disclosure

SEC source: 0001209191-12-008709 · doc4.xml · nonDerivative · entry 1

HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,676,233.872

F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.